Taro Pharmaceutical Industries Ltd. (TARO)

42.45 -0.06 (-0.14%) 收市：04:00PM EDT

Taro Pharmaceutical Industries Ltd.

14 Hakitor Street
Haifa Bay
Haifa 2624761
Israel
972 4 847 5700
https://www.taro.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 1,554

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Uday V. Baldota	CEO & Director	無	無	1970
Mr. William J. Coote	VP, CFO & Chief Accounting Officer	無	無	1955
Mr. Itamar Karsenti	VP & Head of Operations	無	無	1972
Mr. Avi Avramoff	VP and Head of R&D	無	無	1965
Mr. Itzik Baruch	Vice President of Technical Services	無	無	1963
Dr. Roman Kaplan	Vice President of Scientific and Technical Compliance Manager	無	無	1947
Mr. Erik Zwicker J.D.	VP, General Counsel & Secretary	無	無	1980
Mr. Ara Aprahamian	Vice President of Sales & Marketing	616.14k	無	1968
Ms. Michele Visosky	VP & Head of Human Resource	無	無	1966
Mr. Jayesh Shah	Head of Procurement	無	無	1956

截止 2017年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

公司管治

截至 無 止，Taro Pharmaceutical Industries Ltd. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。